פרופ' עוזי גפטר

אמריטוס במחלקות קליניות
מחלקות קליניות אמריטוס

מידע כללי

Head of Nephrology & Hypertension Department

Rabin Medical Center

Laboratory of Nephrology, Felsenstein Medical Research Center, Sackler School of Medicine,
Tel Aviv University 

קורות חיים

Education

1966-1972     Hebrew University Hadassa Medical School, Jerusalem, Israel

1973               M.D. Degree

1973-1977     Hasharon Hospital, Tel Aviv University Sackler School of Medicine, Israel

1979               Internal Medicine – American Board Certificate

1978-1980     UCLA Medical School, LA, USA – Nephrology

1980               Nephrology – American Board Certificate

1980               Israeli Board Certificate – Internal Medicine, Nephrology

1990-1996     Life sciences, Bar Ilan University, Ramat Gan, Israel

1996               Ph.D. with highest distinction

 

Academic and other positions

1996 – Full Professor of Medicine, Sackler Faculty of Medicine, Tel Aviv University

תחומי מחקר

Research areas

Effect of obesity on kidney physiology, histologyand function – human in-vivo and in-vitro studies.

Kidney lipotoxicity in diabetes and obesity – studies in humans kidney biopsies with RNA, DNA and protein determinations.

DNA damage and repair – studies in-vivo and in-vitro in humans with CRF, kidney transplantations, with special interest in carcinogenesis and transplantation.

Phosphate nephropathy – clinical studies in humans. Studies of glomerulonephritis in rat models.

פרסומים

List of publications (2008-2012)

1.        Herman M, Ori Y, Korzets A, Chagnac A, Malachi T, Gafter U.
Spontaneous DNA repair increases during hemodialysis .
Nephron Clin Prac 108:c188-193, 2008
 

2.        Korzets A, Azoulay O, Ori Y, Zevin D, Boaz M, Herman M, Chagnac A, Gafter U.
The use of intradialytic parenteral nutrition in acutely ill hemodialysed patients.
J Ren Care 34:14-18, 2008
 

3.        Erman A, Milo G, Genkin I, Rachamimov O, van Dijk DJ, Gafter U.
Losartan reduces kidney cortex ACE activity and kidney angiotensin II level in the streptozotocin-diabetic rat.
J Chin Clin Med 3: 181-189, 2008
 

4.        Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M.
Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: Systematic review and meta-analysis of randomized, controlled trials.
Clin Infect Dis 47:83-89, 2008
 

5.        Avry Chagnac,  Michal Herman, Boris Zingerman, Arie Erman, Benaya Rozen-Zvi, Judith Hirsh, Uzi Gafter
Obesity Induced Glomerular Hyperfiltration:  Its Involvement in the Pathogenesis of Tubular Sodium Reabsorption.
Nephrol Dial Transplant 23: 3946-3952, 2008
 

6.        Rozen-Zvi B, Gafter-Gvili A, Paul M, Leibovici L, Shpilberg O, Gafter U
Intravenous versus oral iron supplementation fo the treatment of anemia in chronic kidney disease: Systematic review and meta-analysis
Am J Kidney Dis 52: 897-906, 2008
 

7.        Ori Y, Herman M, Tobar A, Chernin G, Gafter U, Chagnac A, Ben Izhak O, Korzets A.
Acute phosphate nephropathy – “An emerging threat”.
Am J Med Sci 336: 309-314, 2008
 

8.        Korzets A, Gafter U, Chagnac A, Zingerman B, Morduchovitz V, Ori Y.
Thalidomide: A treatment option for bleeding GI angiodysplasias in dialysed patients.
Nephrol Dial Transplant Plus 1: 354-356, 2008
 

9.        Freidkin I, Herman M, Tobar A, Chagnac A, Ori Y, Korzets A, Gafter U.
Effects of histone deacetylase inhibitors on rat mesangial cells.
Am J Physiol-Renal Physiol 298:F426-434, 2010
 

10.     Rozen-Zvi B, Yahav D, Gheorghiade M, Korzets A, Leibovici L, Gafter U.
Vasopressin receptor antagonist for the treatment of hyponatremia – systematic review and meta analysis.
Am J Kidney Dis 56:325-337, 2010
 

11.     Fattal I, Shental N, Mevorach D, Anaya JM, Livneh A, Langevitz P, Zandman-Goddard G, Pauzner R, Lerner M, Blank M, Hincapie ME, Gafter U, Naparstek Y, Shoenfeld Y, Domany E, Cohen IR
An antibody profile of systemic lupus erythematosus detected by antigen microarray.
Immunology 130:337-343, 2010
 

12.     Madar H, Korzets A, Ori Y, Herman M, Levy-Drummer RS, Gafter U, Chagnac A. Residual renal function in peritoneal dialysis after renal transplant failure
Perit Dial Int  30:470-474, 2010
 

13.     Gafter-Gvili A, Ram R, Gafter U, Shpilberg O, Raanani P.
Renal failure associated with tyrosine kinase inhibitors--case report and review of the literature.
Leuk Res. 2010 Jan;34:123-127
 

14.     Boaz M, Katzir Z, Schwartz D, Gafter U, Biro A, Shtendik L, Kon V, Chernin G, Weinstein T.
Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients.
Nephron Clin Pract 117(2):c83-c88, 2010
 

15.     Gafter-Gvili A, Herman M, Ori Y, Korzets A, Chagnac A, Zingerman B, Rozen-Zvi B, Gafter U, Malachi T.
Inhibition of mitochondrial function reduces DNA repair in human mononuclear cells.
Leuk Res 35:219-225, 2011
 

16.     Dinour D, Bahn A, Ganon L, Ron R, Geifman-Holtzman O, Knecht A, Gafter U, Rachamimov R, Sela BA, Burckhardt G, Holtzman EJ.
URAT1 mutations cause renal hypouricemia type 1 in Iraqi Jews.
Nephrol Dial Transplant 26:2175-2181, 2011
 

17.     Erman A, Rahamimov R, Mashraki T, Levy-Drummer RS, Winkler J, David I, Hirsh Y, Gafter U, Chagnac A.
The Urine Albumin-to-Creatinine Ratio: Assessment of Its Performance in the Renal Transplant Recipient Population.
Clin J Am Soc Nephrol 6:892-897, 2011
 

18.      Green H, Rahamimov R, Gafter U, Leibovitci K, Paul M.
Antibiotic prophylaxis for urinary tract infections in renal transplant recipients: a systematic review and meta-analysis.
Transpl Infect Dis 13:441-447, 2011
 

19.      Gafter-Gvili A, Herman M, Ori Y, Korzets A, Chagnac A, Zingerman B, Rozen-Zvi B, Gafter U, Malachi T.
Inhibition of mitochondrial function reduces DNA repair in human mononuclear cells.
Leuk Res 35:219-225, 2011
 

20.      Boaz M, Katzir Z, Schwartz D, Gafter U, Biro A, Shtendik L, Kon V, Chernin G, Weinstein T.
Effect of sevelamer hydrochloride exposure on carotid intima media thickness in hemodialysis patients.
Nephron Clin Pract. 2011;117(2):c83-8. .

 

21.      Herman-Edelstein M, Rozen-Zvi B, Zingerman B, Lichtenberg S, Malachi T, Gafter U, Ori Y.
Effect of immunosuppressive drugs on DNA repair in human peripheral blood mononuclear cells.
Biomed Pharmacother 66:111-115, 2012
 

22.     Ori Y, Rozen-Zvi B, Avry Chagnac, Herman M, Zingerman B, Atar E, Gafter U, Korzets A.
Fatalities and severe metabolic disorders associated with the use of sodium phosphate enemas: a single center's experience.
Arch Intern Med 172:263-265, 2012

 

23.     Rozen-Zvi B*, Gafter-Gvili A*, Zingerman B, Levy-Drummer R, Levi L, Mor E, Gafter U, Rahamimov R.
Intravenous iron supplementation after kidney transplantation.
Clin Transplant 26:608-614, 2012

 

24.     Ori Y*, Herman-Edelstein M*, Zingerman B, Rozen-Zvi B, Gafter U, Malachi T, Gafter-Gvili A.
Effect of immunosuppressive drugs on spontaneous DNA repair in human peripheral blood mononuclear cells.
Biomed Pharmacother  66(6):409-413, 2012
 

25.     Rozen-Zvi B, Ben-Avraham B, Schneider S, Gafter-Gvili A, Levy-Drummer RS, Zingerman B, Mor E, Gafter U, Rahamimov R.
Haemoglobin variability in the early post-transplant period: Association with graft survival and mortality.
Nephrology 18:148-156, 2013
 

26.     Herman-Edelstein M, Weinstein T, Gafter U.
TGFβ1-dependent podocyte dysfunction.
Curr Opin Nephrol Hypertens 22:93-99, 2013
 

27.     Green H, Rahamimov R, Goldberg E, Leibovici L, Gafter U, Bishara J, Mor E, Paul M.
Consequences of treated versus untreated asymptomatic bacteriuria in the first year following kidney transplantation: retrospective observational study.
Eur J Clin Microbiol Infect Dis 32:127-131, 2013
 

28.     Gafter-Gvili A*, Rozen-Zvi B*, Vidal L, Leibovici L, Vansteenkiste J, Gafter U, Shpilberg O.
Intravenous iron supplementation for the treatment of chemotherapy-induced anaemia - systematic review and meta-analysis of randomised controlled trials.
Acta Oncol 52:18-29, 2013
 

29.     Ori Y, Chagnac A, Korzets A, Zingerman B, Herman-Edelstein M, Bergman M, Gafter U, Salman H.
Regression of left ventricular hypertrophy in patients with primary aldosteronism / low renin hypertension on low dose spironolactone
Nephrol Dial Transplant 2013 (Ahead of print)
 

30.     Ori Y, Bergman M, Bessler H, Zingerman B, Levy-Drummer R, Gafter U, Salman H.
Cytokines secretion and markers of inflammation in relation to acidosis among chronic hemodialysis patients.
Blood Purification 2013 (Accepted for publication)
 

31.     A. Gafter-Gvili, B. Zingerman, B. Rozen-Zvi, Y. Ori, H. Green, I. Lubin,
 T. Malachi, U. Gafter, M. Herman-Edelstein.
Oxidative Stress-Induced DNA Damage and Repair in Human Peripheral Blood Mononuclear Cells: Protective Role of Hemoglobin.
Plos One 2013 (Accepted for publication)

אוניברסיטת תל אביב עושה כל מאמץ לכבד זכויות יוצרים. אם בבעלותך זכויות יוצרים בתכנים שנמצאים פה ו/או השימוש
שנעשה בתכנים אלה לדעתך מפר זכויות נא לפנות בהקדם לכתובת שכאן >>